NCT00010283已完成1 期
Oral Beclomethasone Dipropionate Capsules for Treatment of Intestinal Graft-Versus-Host Disease: Compassionate Use in Patients With Contraindictions to High-Dose Immunosuppressive Therapy
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
RATIONALE: Beclomethasone may be an effective treatment for graft-versus-host disease.
PURPOSE: Phase I/II trial to study the effectiveness of beclomethasone in treating patients who have graft-versus-host disease of the esophagus, stomach, small intestine, or colon.
详细描述
OBJECTIVES: I. Determine the frequency of treatment success in patients with intestinal graft-versus-host disease with contraindications to high-dose immunosuppressive therapy treated with beclomethasone. II. Determine the frequency of adverse events related to the use of this drug in these patients. III. Assess the natural history and outcome of the medical problem for which high-dose immunosuppressive therapy was a contraindication.
OUTLINE: Patients receive oral beclomethasone 4 times daily for 28 days. Treatment may repeat for an additional 28 days as needed. Patients are interviewed weekly to assess treatment success and adverse events. Patients are followed at 1 and 2 weeks.
PROJECTED ACCRUAL: A total of 40-100 patients will be accrued for this study within 3 years.
研究设计
- 研究类型
- Interventional
- 主要目的
- Supportive Care
入排标准
- 年龄范围
- 5 Years 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •DISEASE CHARACTERISTICS: Histologically proven intestinal (esophagus, stomach, small intestine, or colon) graft-versus-host disease (GVHD) exhibiting symptoms such as nausea, vomiting, anorexia, diarrhea, or abdominal pain in the absence of another explanation for these symptoms Specific contraindications to high-dose immunosuppressive therapy, such as: Recurrent malignant disorder for which an allogeneic antitumor effect is desired Aspergillus or other fungal infection Severe myopathy, hyperglycemia, bone problems, or neuropsychiatric symptoms related to corticosteroid use Thrombotic thrombocytopenic purpura or hemolytic uremic syndrome related to immunosuppressive therapy Epstein-Barr virus-related immunoproliferative disease No GVHD unresponsive to prior high-dose immunosuppressive therapy No concurrent infections involving the intestinal tract such as: Salmonella Shigella Clostridium difficile (toxin positive) Rotavirus Giardia lamblia Cytomegalovirus by shell vial culture
- •PATIENT CHARACTERISTICS: Age: 5 to 75 Performance status: Not specified Life expectancy: Not specified Hematopoietic: Platelet count adequate Hepatic: Not specified Renal: Not specified Other: Able to swallow oral capsules No persistent vomiting of all oral intake No multiorgan failure No sepsis syndrome, including positive bacterial or fungal cultures within 72 hours of study
- •PRIOR CONCURRENT THERAPY: Biologic therapy: At least 7 days since prior anti-thymocyte globulin Chemotherapy: Concurrent cyclosporine, methotrexate, tacrolimus, mycophenolate mofetil, or prednisone allowed if plan in place to taper or discontinue Endocrine therapy: See Disease Characteristics Radiotherapy: Not specified Surgery: Not specified Other: At least 7 days since prior investigational agents At least 7 days since prior immunosuppressive agents At least 24 hours since prior drugs that suppress gastric acid secretion (e.g., H2 receptor antagonists or omeprazole) No concurrent drugs that suppress gastric acid secretion
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal TractGraft Versus Host DiseaseNCT00055666Roswell Park Cancer Institute51
已完成
2 期
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Chronic Eosinophilic LeukemiaHematopoietic/Lymphoid CancerAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Childhood Acute Myeloid Leukemia in RemissionChronic Phase Chronic Myelogenous LeukemiaContiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaContiguous Stage II Grade 3 Follicular LymphomaNodal Marginal Zone B-cell LymphomaNoncontiguous Stage II Adult Immunoblastic Large Cell LymphomaNoncontiguous Stage II Small Lymphocytic LymphomaRecurrent Adult Acute Lymphoblastic LeukemiaPrimary MyelofibrosisAtypical Chronic Myeloid LeukemiaChildhood Chronic Myelogenous LeukemiaContiguous Stage II Adult Burkitt LymphomaGraft Versus Host DiseaseNoncontiguous Stage II Grade 2 Follicular LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult T-cell Leukemia/LymphomaRecurrent Grade 1 Follicular LymphomaRecurrent Grade 3 Follicular LymphomaStage I Adult Immunoblastic Large Cell LymphomaStage I Grade 1 Follicular LymphomaStage II Adult Hodgkin LymphomaStage III Adult Hodgkin LymphomaContiguous Stage II Adult Diffuse Large Cell LymphomaContiguous Stage II Adult Diffuse Mixed Cell LymphomaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Mantle Cell LymphomaMyelodysplastic/Myeloproliferative Disease, UnclassifiableNoncontiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Grade 3 Follicular LymphomaRecurrent Adult Diffuse Mixed Cell LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Lymphoblastic LymphomaRelapsing Chronic Myelogenous LeukemiaStage I Adult Diffuse Mixed Cell LymphomaStage I Cutaneous T-cell Non-Hodgkin LymphomaStage I Small Lymphocytic LymphomaStage II Adult T-cell Leukemia/LymphomaStage II Chronic Lymphocytic LeukemiaStage II Multiple MyelomaStage III Multiple MyelomaStage III Small Lymphocytic LymphomaStage IV Adult Diffuse Small Cleaved Cell LymphomaStage IV Adult Hodgkin LymphomaStage IV Adult T-cell Leukemia/LymphomaStage IV Chronic Lymphocytic LeukemiaStage IV Marginal Zone LymphomaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With t(8;21)(q22;q22)Childhood Acute Lymphoblastic Leukemia in RemissionContiguous Stage II Marginal Zone LymphomaNoncontiguous Stage II Grade 1 Follicular LymphomaNoncontiguous Stage II Mantle Cell LymphomaNoncontiguous Stage II Marginal Zone LymphomaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Marginal Zone LymphomaRecurrent/Refractory Childhood Hodgkin LymphomaStage I Adult Burkitt LymphomaStage I Adult Hodgkin LymphomaStage I Adult Lymphoblastic LymphomaStage I Grade 2 Follicular LymphomaEssential ThrombocythemiaAdult Acute Myeloid Leukemia With t(16;16)(p13;q22)Blastic Phase Chronic Myelogenous LeukemiaChildhood Myelodysplastic SyndromesJuvenile Myelomonocytic LeukemiaChronic Neutrophilic LeukemiaContiguous Stage II Adult Immunoblastic Large Cell LymphomaContiguous Stage II Adult Lymphoblastic LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Small Lymphocytic Lymphomade Novo Myelodysplastic SyndromesExtramedullary PlasmacytomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueIsolated Plasmacytoma of BoneMeningeal Chronic Myelogenous LeukemiaNoncontiguous Stage II Adult Burkitt LymphomaNoncontiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaNoncontiguous Stage II Adult Lymphoblastic LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisRecurrent Adult Hodgkin LymphomaRecurrent Mantle Cell LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Adult Diffuse Large Cell LymphomaStage I Adult Diffuse Small Cleaved Cell LymphomaStage I Adult T-cell Leukemia/LymphomaStage I Childhood Hodgkin LymphomaStage I Chronic Lymphocytic LeukemiaStage I Grade 3 Follicular LymphomaStage III Adult Burkitt LymphomaStage III Adult Diffuse Mixed Cell LymphomaStage III Adult Diffuse Small Cleaved Cell LymphomaStage III Adult T-cell Leukemia/LymphomaStage III Cutaneous T-cell Non-Hodgkin LymphomaStage III Grade 1 Follicular LymphomaRecurrent Adult Acute Myeloid LeukemiaRecurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Hairy Cell LeukemiaSecondary Myelodysplastic SyndromesStage I Mantle Cell LymphomaStage I Mycosis Fungoides/Sezary SyndromeStage III Adult Immunoblastic Large Cell LymphomaStage III Chronic Lymphocytic LeukemiaStage IV Adult Immunoblastic Large Cell LymphomaStage IV Small Lymphocytic LymphomaStage I Marginal Zone LymphomaStage I Multiple MyelomaStage II Cutaneous T-cell Non-Hodgkin LymphomaStage II Mycosis Fungoides/Sezary SyndromeStage III Adult Diffuse Large Cell LymphomaStage III Grade 3 Follicular LymphomaStage IV Adult Burkitt LymphomaStage IV Adult Diffuse Mixed Cell LymphomaStage IV Grade 2 Follicular LymphomaStage III Adult Lymphoblastic LymphomaStage III Mantle Cell LymphomaStage III Marginal Zone LymphomaStage III Mycosis Fungoides/Sezary SyndromeStage III Grade 2 Follicular LymphomaStage IV Adult Diffuse Large Cell LymphomaStage IV Adult Lymphoblastic LymphomaStage IV Cutaneous T-cell Non-Hodgkin LymphomaStage IV Grade 1 Follicular LymphomaStage IV Grade 3 Follicular LymphomaStage IV Mycosis Fungoides/Sezary SyndromeChronic Myelomonocytic LeukemiaNCT00489203Fred Hutchinson Cancer Center140
已完成
3 期
Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host DiseaseGraft Versus Host DiseaseNCT00043147Memorial Sloan Kettering Cancer Center
已完成
不适用
Oral Beclometasone dipropionate for for gut GVHDGut Graft-versus-host diseaseJPRN-UMIN000031703Department of Pediatrics, University of Ryukyus, hospital1
已完成
不适用
Oral beclomethasone dipropionate treatment for gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantatioPatients with symptoms of acute gastrointestinal GVHD after allo-HSCTJPRN-UMIN000027026Tokyo Women's Medical University, Department of Hematology5